Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists

The incidence of type 2 diabetes (T2D) has been increasing worldwide, and diabetic kidney disease (DKD) remains one of the leading long-term complications of T2D. Several lines of evidence indicate that glucose-lowering agents prevent the onset and progression of DKD in its early stages but are of l...

Descripción completa

Detalles Bibliográficos
Autores principales: Winiarska, Agata, Knysak, Monika, Nabrdalik, Katarzyna, Gumprecht, Janusz, Stompór, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509708/
https://www.ncbi.nlm.nih.gov/pubmed/34639160
http://dx.doi.org/10.3390/ijms221910822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509708/
https://www.ncbi.nlm.nih.gov/pubmed/34639160
http://dx.doi.org/10.3390/ijms221910822

Ejemplares similares